Summit Therapeutics (SMMT) Appoints Jeff Huber to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
June 27, 2024 4:15 PM EDTMIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced that Jeff Huber has been appointed to its Board of Directors, effective immediately.
It is an honor to add Jeff Huber to our excellent, diverse group of board members, stated Robert W. Duggan, Chairman and Chief Executive Officer of Summit. Jeffs executive leadership experience in healthcare and technology and his countless accomplishments evidence his ability to translate whats possible into transformational success. As we seek to change the standard of care for solid tumors based on the potential of... More
